Tübingen, Germany

Dominik Buob

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2023

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Dominik Buob: Innovator in RNA Capping Technology

Introduction

Dominik Buob is a notable inventor based in Tübingen, Germany. He has made significant contributions to the field of biotechnology, particularly in the area of RNA capping technology. His innovative work has implications for various applications in molecular biology and therapeutic development.

Latest Patents

Dominik Buob holds a patent for a "Method for adding cap structures to RNA using immobilized enzymes." This invention relates to an immobilized capping enzyme, specifically an immobilized Vaccinia virus capping enzyme. Additionally, it includes an immobilized cap-specific nucleoside 2'-O-methyltransferase, also preferably derived from the Vaccinia virus. The patent outlines methods for immobilizing these enzymes and utilizing them to add a 5'-cap structure to RNAs. Furthermore, it describes an enzyme reactor designed for performing the capping reaction and separating the resulting 5'-capped RNA product. A kit comprising the capping enzyme and/or the cap-specific nucleoside 2'-O-methyltransferase is also included in the invention.

Career Highlights

Throughout his career, Dominik Buob has worked with prominent companies in the biotechnology sector, including CureVac SE and CureVac AG. His experience in these organizations has allowed him to develop and refine his expertise in RNA technology and enzyme applications.

Collaborations

Dominik has collaborated with notable colleagues such as Tilmann Roos and Benyamin Yazdan Panah. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Dominik Buob is a pioneering inventor whose work in RNA capping technology has the potential to impact various fields within biotechnology. His innovative methods and collaborations highlight his commitment to advancing scientific knowledge and applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…